Blog / Archives
Large Cap Biopharma Winners YTD: Looking for Growth and Value in a Choppy Market..Update-2 BIG movers
Update-2 3p EDT BIOTECH Movers from our SMID trading list: EYPT up 14% to $10.46, ADPT up 10.4% to $1.74. Also many stocks are on top of daily range. Gilead Sciences (GILD) makes a new oncology deal...
Biotech stocks Wobble a bit after a Grueling Week but Deals and Clinical News can Drive Stocks Higher…Update-3…FED on hold
6/18/25...FED on hold with economy ok but tariffs creating uncertainty-rates unchanged. Nice little rally in SMID biotechs with both ARKG and XBI holding. Modest gains in GH, LGND,NTRA, ROIV, RXRX,...
ASCO Week Recap by the Numbers-some Good Progress with Longer Term Issues…Update-1 Biotechs remain strong
Update-1 6/10/25 ...Post ASCO rally: Biotech stocks remained strong from the ASCO Conference with good momentum from SMID caps. ARKG and XBI led the rally. Most mid-caps from our trading list were...
May 2025 was a Great Month for Stocks up 6% so why aren’t you more bullish?…ASCO rally renews! Update-3
Update-3 ..6/6/25 11:45a. Green screen rally in SMID biotechs ! TECH stocks strong. 330p EDT: I dont know why the SMID biotechs are taking off today but some of it is ETF buying (XBI) here is a...
Can Biotech Stocks Regain Momentum Amidst the Chaos?…Update-2…Risk off due to tariff whipsaw…
Update-2 5/3010a EDT..... WHIPSAWED. Changed course again after Trump comments on China roil markets-risk off. Renewed escalation in tensions with China. You have heard the magic word before...
With the Healthcare Sector in Turmoil Should You Rebalance Your Portfolio? Update-3…C’mon Back Biotech at ASCO!
Update-3 5/22-23..... 10:50a EDT....VIGL continues to run on Sanofi acquisition.at $8/sh. Should spark our SMID biotech trading list but XBI is stuck at $78. Ahead of ASCO we should see more green...
Stocks Show Resilience looking Beyond Tariffs, even healthcare gets a nibble
Stocks Show Resilence off early April Lows A nice week despite uncertainty from tariffs with the S&P 500 up 5% and NASDAQ up 7%. Healthcare and biotech stocks were still selling off until the...
SMID Biotech April Rally Ended as Stocks Take a Dive on NEWS…5/12/25..UPDATE-4
Update-4..5/13...3:15 p TECH and SEMI rally but nothing for biotech and UNH is a disaster. Too volatile for trading. XBI at $77+. Update-3...5/12..10a EDT. HUGE rally on China opening deal??...In...
SMID Biotech Stocks Poised for a Move This Quarter: Is the Innovation Trade Back?..Update-2 5/4… ADPT, other movers…
Update-2 5/4/24: a great week for SMID biotechs here are some winners; From our trading list stocks near 52 week highs: ADMA, ADPT, BBIO, CPRX, EXEL, GH, RYTM. XBI at $83.50 down 7.28% YTD, up 3.6%...
Large Cap Biopharmaceutical Update: Mixed Performance as Tariffs Loom…Update-2…4/29…Good gains in pharma and medtech
Update-2..4/29...3p EDT...Novartis (NVS) stock up over 1% on earnings beat raised guidance. Broad pipeline in four therapeutic areas. Good value with FWD PE of 14.9,PS of 4.3, Div.of 3.5%, RSI...